(→Bring DNA Closer tool construction) |
(→Bring DNA Closer tool construction) |
||
Line 30: | Line 30: | ||
'''We have designed a tool based on the CRISPR/Cas9 system to target a specific DNA sequence. We imagined a system using a dCas9 that dimerizes under an induction signal to bring two DNA sequences closer. ''' | '''We have designed a tool based on the CRISPR/Cas9 system to target a specific DNA sequence. We imagined a system using a dCas9 that dimerizes under an induction signal to bring two DNA sequences closer. ''' | ||
− | A dCas9 is a protein which recognizes precisely a DNA sequence without nuclease activity. We chose this system for its high adaptability, as it targets DNA through a sgRNA which could be easily designed. But as we need to target two different sequences we also need to work with dCas9s which will not interfere with each other. Thus we chose two orthologous dCas9s which are respectively expressed by ''T. denticola'' (TD) and ''S. pyogenes'' (SP). As they come from different organisms, they recognize different sgRNAs thanks to their PAM sequence. We ordered from Addgene the plasmids coding for each one of these dCas9s and their sgRNAs. | + | A dCas9 is a protein which recognizes precisely a DNA sequence without nuclease activity (cf '''Fig1'''). We chose this system for its high adaptability, as it targets DNA through a sgRNA which could be easily designed. But as we need to target two different sequences we also need to work with dCas9s which will not interfere with each other. Thus we chose two orthologous dCas9s which are respectively expressed by ''T. denticola'' (TD) and ''S. pyogenes'' (SP). As they come from different organisms, they recognize different sgRNAs thanks to their PAM sequence. We ordered from Addgene the plasmids coding for each one of these dCas9s and their sgRNAs. |
[[Image:Image1design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | [[Image:Image1design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | ||
Line 37: | Line 37: | ||
− | To dimerize this two dCas9s, we chose an inducible system using the FRB and FKBP12 proteins. Originally found in mammals, these two proteins form an heterodimer when rapamycin is added in the middle. It is particularly used in protein interaction studies (Cui et al., 2014). However, rapamycin is toxic for bacteria, but studies showed that a mutated FRB (FRB*) still allows dimerization with a non toxic analog of rapamycin called rapalog. The mutations implied are: T2098L, K2095P, W2101F.(Bayle et al., 2006; Liberles, Diver, Austin, & Schreiber, 1997). | + | To dimerize this two dCas9s, we chose an inducible system using the FRB and FKBP12 proteins (cf '''Fig2'''). Originally found in mammals, these two proteins form an heterodimer when rapamycin is added in the middle. It is particularly used in protein interaction studies (Cui et al., 2014). However, rapamycin is toxic for bacteria, but studies showed that a mutated FRB (FRB*) still allows dimerization with a non toxic analog of rapamycin called rapalog. The mutations implied are: T2098L, K2095P, W2101F.(Bayle et al., 2006; Liberles, Diver, Austin, & Schreiber, 1997). |
A biobrick coding for FRB with the mutation T2098L was already in the iGEM registry (iGEM Part_ J18926) but was not available. Moreover, it contains only one mutation on the 3 described in the literature. So we decided to work with the fully mutated FRB. The rapalog and the plasmid containing the mutated FRB and FKBP12 were offered to us by Takara Clontech. But as mentioned previously, this system is used in mammal cells, so we decided to optimize the sequences for an expression in ''E. coli'' with the Jcat plateforme. So we finally ordered gBlocks coding for the FRB* and FKBP12 optimized sequences and a linker in prevision for the fusion with their respective dCas9s. | A biobrick coding for FRB with the mutation T2098L was already in the iGEM registry (iGEM Part_ J18926) but was not available. Moreover, it contains only one mutation on the 3 described in the literature. So we decided to work with the fully mutated FRB. The rapalog and the plasmid containing the mutated FRB and FKBP12 were offered to us by Takara Clontech. But as mentioned previously, this system is used in mammal cells, so we decided to optimize the sequences for an expression in ''E. coli'' with the Jcat plateforme. So we finally ordered gBlocks coding for the FRB* and FKBP12 optimized sequences and a linker in prevision for the fusion with their respective dCas9s. | ||
− | Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool based on the two following BioBricks: | + | Using these two systems (dCas9 recognition and FRB/FKBP12 dimerization) we design our new tool (cf '''Fig2''' and '''Fig3''') based on the two following BioBricks: |
[[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] | [[Image:Image2design.jpg|frameless|center|upright=2.5|alt=dCas9 mecanism]] |
Revision as of 14:14, 17 October 2016